SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.
Contract Category
3 federal contract opportunities classified as Gene Therapy.
AI Summary
The BioStabilization Systems (BoSS) program seeks innovative solutions to enhance the stabilization and distribution of live cell-based therapies. Interested parties must submit Solution Summaries by specified deadlines in 2026. This opportunity focuses on advancing bioprocessing technologies to improve healthcare deli…
MD
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The National Institutes of Health intends to negotiate a sole source contract with Mission Bio for Tapestri reagent kits and cartridges. This acquisition supports clinical research in cellular engineering, particularly for CAR-T cell manufacturing. Interested vendors may submit capability statements by May 8, 2026, for…
MD
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The Department of Health and Human Services is seeking to acquire Cytiva NanoAssemblr Ignite and Spark microfluidic nanoparticle formulation systems for gene therapy development. This opportunity is categorized as a Special Notice and is relevant for suppliers of biotechnology equipment and medical devices.
MD
Common questions about finding and winning Gene Therapy government contracts.